{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:55:12Z","timestamp":1779148512602,"version":"3.51.4"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND AND PURPOSE<\/jats:bold> Lithocholic acid (LCA), the most toxic bile acid, induces cholestatic liver injury in rodents. We previously showed that LCA activates the oxidative stress\u2010responsive nuclear factor (erythroid\u20102 like), factor 2 (Nrf2) in cultured liver cells, triggering adaptive responses that reduce cell injury. In this study, we determined whether Nrf2 protects the liver against LCA\u2010induced toxicity <jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>EXPERIMENTAL APPROACH<\/jats:bold> Nrf2 disrupted (<jats:italic>Nrf2<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>) and wild\u2010type mice were treated with LCA (125\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup> body weight) to induce liver injury. Levels of mRNA, protein and function of important Nrf2 target genes coupled with liver histology and injury biomarkers of mice were examined.<\/jats:p><jats:p><jats:bold>KEY RESULTS<\/jats:bold> In 4 day LCA treatments, we observed a significantly higher hepatic induction of Nrf2 target, cytoprotective genes including thioredoxin reductase 1, glutamate cysteine ligase subunits, glutathione S\u2010transferases, haeme oxygenase\u20101 and multidrug resistance\u2010associated proteins 3 and 4 in the wild type as compared with the <jats:italic>Nrf2<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. Moreover, basal and LCA\u2010induced hepatic glutathione and activities of glutathione S\u2010transferases and thioredoxin reductases were higher in wild\u2010type than in <jats:italic>Nrf2<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. This reduced production of cytoprotective genes against LCA toxicity rendered <jats:italic>Nrf2<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice more susceptible to severe liver damage with the presence of multifocal liver necrosis, inflamed bile ducts and elevation of lipid peroxidation and liver injury biomarkers, such as alanine aminotransferase and alkaline phosphatase.<\/jats:p><jats:p><jats:bold>CONCLUSIONS AND IMPLICATIONS<\/jats:bold> Nrf2 plays a crucial cytoprotective role against LCA\u2010induced liver injury by orchestrating adaptive responses. The pharmacological potential of targeting liver Nrf2 in the management of cholestatic liver diseases is proposed.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00953.x","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T19:41:38Z","timestamp":1278531698000},"page":"1111-1121","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Participation of nuclear factor (erythroid 2\u2010related), factor 2 in ameliorating lithocholic acid\u2010induced cholestatic liver injury in mice"],"prefix":"10.1111","volume":"161","author":[{"given":"KP","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GA","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1379\/CSC-217.1"},{"issue":"1","key":"e_1_2_8_3_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 4th edition","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.05.033"},{"key":"e_1_2_8_5_1","first-page":"549","article-title":"Bile salts and renal funjction in biliary cirrhosis","volume":"17","author":"Bomzon A","year":"1997","journal-title":"Semin Nephrol"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.10.001"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050404"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(96)06305-X"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.040634"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2006.04.014"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21519"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.32.20096"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6943"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M805804200"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.46.120604.141046"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01316.2006"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.06.005"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.5.710"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3180653ce6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21831"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21158"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R900010200"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90321.2008"},{"key":"e_1_2_8_24_1","first-page":"476","article-title":"Elevated level of serum Mn\u2010superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis","volume":"118","author":"Ono M","year":"1997","journal-title":"J Lab Clin Med"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.023"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/152308604771978336"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jn\/129.1.194","article-title":"Aurothioglucose inhibits murine thioredoxin reductase activity in vivo","volume":"129","author":"Smith AD","year":"1999","journal-title":"J Nutr"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051551698"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.039370"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.09.010"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(93)90247-2"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051014398"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22908"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00953.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00953.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:12:03Z","timestamp":1697440323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00953.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00953.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00953.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]},"assertion":[{"value":"2010-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}